With the CDC director's chair still empty, HHS Secretary Robert F. Kennedy Jr. endorsed recommendations made months ago by ...

The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60.

The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of vaccine experts in April, ...

Ritchey cited early signs of respiratory syncytial virus, or RSV, starting to increase this season as expected in Florida, which is called out at the top of this week's report. Behind the CDC's ...

Studies presented to the CDC ACIP Work Group for RSV found both vaccines from fall 2023 may result in a slightly elevated risk of Guillain-Barré syndrome, a rare but serious condition.

When you buy through links on our articles, Future and its syndication partners may earn a commission. Adults ages 75 and older should get a single dose of an RSV vaccine, the CDC says. Younger ...

In adults 60 and over, vaccine effectiveness from October 2023 to March 2024 against RSV-associated hospitalization reached 75% (95% CI 50-87), according to researchers led by Diya Surie, MD, of ...

The CDC says that, yearly, RSV leads to 58,000–80,000 hospitalizations among children younger than 5 years old and 100,000–150,000 hospitalizations among adults 60 years and older.